Indapamida Ciclum (Indapamide)

Indapamide inhibits the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. By blocking this transporter, it reduces reabsorption of sodium and chloride, leading to increased urine output. The resulting loss of fluid lowers blood volume, decreases peripheral vascular resistance, and produces an antihypertensive effect.

The exact dose of Indapamida Ciclum is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Physicians typically start with a standard adult dose and may adjust it as needed, but specific dosing regimens should not be inferred without a prescription.

Safety data for indapamide in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Indapamida Ciclum. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide and hydrochlorothiazide belong to the same thiazide‑like class but differ in potency and duration of action. Indapamide often provides a longer‑lasting antihypertensive effect with a lower incidence of certain metabolic side effects, while hydrochlorothiazide is frequently used for milder hypertension and as a first‑line agent. Choice depends on clinical response and patient tolerance.

Indapamida Ciclum should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but consistent timing each day helps maintain stable blood levels. Patients should follow the dosing schedule prescribed by their clinician and avoid crushing or chewing the tablets unless instructed otherwise.

Serious risks include severe dehydration, marked electrolyte disturbances such as hyponatremia or hypokalemia, and rare allergic reactions that may present as rash, angioedema or anaphylaxis. Prompt medical attention is required if symptoms like extreme weakness, rapid heartbeat, confusion, or swelling of the face and throat occur.

Indapamida Ciclum is contraindicated in patients with anuria (no urine output), severe renal impairment, known hypersensitivity to indapamide or other sulfonamide drugs, and in individuals with severe hepatic disease where safety has not been established. Clinicians should review the patient’s medical history before initiating therapy.